Market Research Logo

European Healthcare EDI Market by Supplier (Distributors and Wholesalers, GPOS, Manufacturers), Purchasing Organization (Hospitals, GPOS), Transaction (Orders, Ordersp, Desadv, Recadv, Invoic), Transaction Types and Its Penetration

European Healthcare EDI Market by Supplier (Distributors and Wholesalers, GPOS, Manufacturers), Purchasing Organization (Hospitals, GPOS), Transaction (Orders, Ordersp, Desadv, Recadv, Invoic), Transaction Types and Its Penetration

European Healthcare EDI Market, [By Supplier (Distributors and Wholesalers, GPOs, Manufacturers), By Purchasing Organization (Hospitals, GPOs), By Transaction (ORDERS, ORDERSP, DESADV, RECADV, INVOIC)] – Transaction Types and Its Penetration”

EDI provides fast, secure, and easy exchange of information between healthcare organizations. These advantages coupled with the growing competitiveness, rising adoption of mobile EDI, pricing pressure, and lower profit margins are driving greater uptake of EDI solutions among pharmaceutical companies and medical device manufacturers in Europe. However, high cost of EDI implementation, lack of infrastructure, and EDI management issues are restrict the overall growth of the market.

In this report, the European healthcare EDI market is segmented based on type of transaction, type of purchasing organization and country. ORDERS, ORDERSP, DESADV, RECADV, and INVOIC are the most popular healthcare EDI transactions in Europe. ORDERS is the most frequently used transaction type used by various healthcare users in the region. In 2015, the EDI penetration rate in Europe was the highest in the U.K., followed by France, Benelux, Denmark, and Germany. It is estimated that EDI adoption is growing at a high rate among hospitals in Europe, with the U.K. accounting for approximately 70% of all European activity. In terms of users, the EDI adoption/penetration is maximum in the hospitals segment, with around 90% hospitals in the region using EDI to place orders with distributors and wholesalers. Among all European countries, the penetration rate of hospital EDI for ORDERS transactions with distributors is highest (97.3%) in the U.K. The penetration rate of orders placed via EDI among GPOs varied from 50%-60%; there has been a considerable rise in EDI adoption among GPOs in Europe over the last few years.

The increasing adoption of EDI solutions among hospitals, operational benefits and increased speed of transaction processing, and growing utilization of EDI solutions in supply chain management are the factors contributing to the growth of healthcare EDI market in Europe. Bayer AG, Pfizer Inc., GlaxoSmithKline PLC, and Abbott Laboratories are the EDI technology leaders in the European pharmaceutical and manufacturing sector.

Reasons to Buy the Report
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market which in turn would help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:
Market Penetration: Comprehensive information on players offering EDI solutions in the European healthcare market. The report analyzes the European healthcare EDI market on the basis of transaction types, purchasing organizations, and suppliers across European countries.
Product Development/Innovation: Detailed insights on the upcoming trends, and hospitals, pharmaceutical and biotechnology companies using EDI solutions in Europe.
Market Development: Comprehensive information on the lucrative emerging EDI transaction types (ORDERS, ORDERSP, DESADV, RECADV, and INVOIC).
Market Diversification: Exhaustive information of transaction types, supplier types, and growing regions in the European healthcare EDI market.

Competitive Assessment: In-depth assessment of adoption strategies, penetration rate, distribution networks, and manufacturing capabilities of the suppliers and purchasing organizations as well as leading players in the European healthcare EDI market


  • INTRODUCTION
    • OBJECTIVES & SCOPE OF THE STUDY
    • SCOPE OF THE STUDY
  • RESEARCH METHODOLOGY
    • SECONDARY RESEARCH
    • PRIMARY RESEARCH
    • ANALYSIS AND OUTPUT
  • EXECUTIVE SUMMARY
    • Healthcare EDI implementation in Europe: Overview
    • Evolution of healthcare EDI in Europe
    • Hospital EDI implementation strategies in Europe
    • Strategic objectives of EDI usage in the healthcare industry
    • Pharmaceutical & medical device companies using EDI solutions in Europe
    • Benefits of Healthcare EDI
    • Healthcare EDI Penetration in Europe
      • Table Healthcare EDI Penetration in European Countries (% of Total Transactions, by Type of Supplier)
  • KEY INSIGHTS
    • STRATEGIC OBJECTIVES OF EDI USAGE IN EUROPEAN HEALTHCARE INDUSTRY
    • BENEFITS OF EDI SOLUTIONS
  • EVOLUTION OF HEALTHCARE EDI IN EUROPE
  • PHARMACEUTICAL & MEDICAL DEVICE COMPANIES USING EDI SOLUTIONS
    • KEY PLAYERS USING EDI SOLUTIONS IN EUROPE
    • LIST OF PHARMACEUTICAL COMPANIES AND THEIR EDI PROVIDERS
    • COMPANY PROFILE: MERCK GROUP
    • COMPANY PROFILE: BAYER AG
    • COMPANY PROFILE: F. HOFFMANN-LA ROCHE AG
    • COMPANY PROFILE: PFIZER, INC.
    • COMPANY PROFILE: ELI LILLY & CO.
    • COMPANY PROFILE: JOHNSON & JOHNSON
  • KEY MARKET TRENDS
    • Growing competitiveness, pricing pressure, and lower profit margins are driving greater uptake of EDI solutions among pharmaceutical companies and medical device manufacturers in Europe
    • Budgetary constraints and cost cutting measures are driving hospitals to adopt EDI solutions in order to optimize their procurement operations and improve efficiency
    • Rising adoption of mobile EDI to ensure quicker management of supply chain operations
    • MARKET CHALLENGES
  • HEALTHCARE EDI PENETRATION IN EUROPE
    • HOSPITALS
      • MEDICATION PROCUREMENT PRACTICES AMONG HOSPITALS
        • Table Europe: Medication Procurement Practices in Hospitals, s, by Country (% of Total Medical Supplies)
      • ADOPTION OF EDI SOLUTIONS AMONG HOSPITALS
        • Table Europe: EDI Penetration in Hospitals, by Transaction (% of Total Transactions)
        • Table Europe: EDI Usag in Hospitals, Transactio (Number of Transactions in Million)
    • GPOs
      • MEDICATION PROCUREMENT PRACTICES AMONG GPOs
        • Table Europe: Medication Procurement Practices inGPOs, by Country (% of Total Medical Supplies)
      • ADOPTION OF EDI SOLUTIONS AMONG GPOs
        • Table Europe : EDI Penetration in GPOs, by Transaction (% of Total Transactions)
        • Table Europe: EDI Usage in GPOs, bTransaction (Numbe of of Transactions in Million)
  • APPENDIX
    • INDUSTRY SPEAKS
    • DETAILS OF PRIMARY DETAILS OF PRIM RESPONDENTS
    • KNOWLEDGE STORE
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report